Streetbeat News

Partnerships

HUGE

KO

FSD Pharma (NASDAQ:HUGE) has signed a Letter of Intent with 1319741 B.C. Ltd., soon to be renamed Celly Nutrition Inc., to grant exclusive rights to recreational applications for FSD Pharma's alcohol misuse technology. The new company will have Coca-Cola (NYSE:KO) veteran John Duffy as CEO and former Celsius CEO Gerry David and marketing expert Kevin Harrington as Advisory Board members.

Portfolio Pulse from Lara Goldstein

June 20, 2023 | 8:48 pm

AMD

SMCI

Supermicro introduces MicroCloud, a high-density 3U 8-node system utilizing AMD Ryzen Zen 4 7000 Series processors. The new server provides a scalable solution for eCommerce, cloud gaming, software development, content creation, and private server instances.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 8:11 pm

LVRO

Lavoro Limited (NASDAQ:LVRO) announced a partnership with German agriculture innovator Stenon to offer real-time soil analyses to its customers in Latin America. The FarmLab tool measures soil parameters such as nitrogen, phosphorus, and magnesium, enabling precise identification of chemical elements necessary for plant growth and yield optimization.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 8:09 pm

WSM

Williams Sonoma has collaborated with floral designer Jeff Leatham to launch a new collection of faux florals, combining Leatham's artistic vision and contemporary designs with Williams Sonoma's commitment to quality and style.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 8:02 pm

DIS

NFLX

Producer Ryan Murphy is planning to leave Netflix for Disney, according to Bloomberg. This move could potentially impact the content offerings of both streaming platforms.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 7:54 pm

TSLA

During a heated Twitter debate on vaccines, Mark Cuban pitched his healthcare company CostPlusDrugs to Elon Musk, suggesting that Musk's companies would benefit from its services. Musk responded positively, saying he would ask Tesla and SpaceX to explore Cuban's proposal.

Portfolio Pulse from AJ Fabino

June 20, 2023 | 7:48 pm

ABBV

RGNX

SRPT

Baird has initiated coverage on RegenXbio Inc (NASDAQ:RGNX) with an Outperform rating and a price target of $42, citing potential gains from AAV gene therapies resurgence. The analyst believes RegenXbio can be a leader in the AAV gene therapy space and that the market underappreciates the opportunity for its partnered ABBV-RGX-314 with AbbVie Inc (NYSE:ABBV). Regenx could also compete with Sarepta Therapeutic Inc's (NASDAQ:SRPT) SRP-9001 in the DMD market.

Portfolio Pulse from Vandana Singh

June 20, 2023 | 6:43 pm

RCAT

Red Cat Holdings has completed the second phase of its artificial intelligence and computer-vision partnership with Athena AI, leading to a surge in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 6:38 pm

RCAT

Red Cat Holdings has completed the second phase of its artificial intelligence and computer-vision partnership with Athena AI for the Teal 2 military-grade drone. Athena's technology successfully performed target recognition and battle tracking during a nighttime test flight, allowing commanders fast decision-making on the battlefield.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 6:31 pm

FXI

NDAQ

Nasdaq executives plan to visit China this year to restart data partnership talks with Chinese companies, aiming to strengthen ties and explore new opportunities.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 6:18 pm